Dyne Therapeutics, Inc. (DYN) vs IDEAYA Biosciences, Inc. (IDYA)
Dyne Therapeutics, Inc. and IDEAYA Biosciences, Inc. are both Biotechnology companies. IDEAYA Biosciences, Inc. is the larger, with a market value of $3.6B against $3.1B — 1.1× the size. Dyne Therapeutics, Inc. has the higher net margin (0.00% vs −74.8%) and the lower return on invested capital (−1,956.3% vs −36.7%). Across the 14 metrics below, IDEAYA Biosciences, Inc. leads on 9 and Dyne Therapeutics, Inc. on 5.
Valuation
Profitability
| Metric | DYN | IDYA | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | (92.66%) | 0.00% |
| Net margin | 0.00% | (74.75%) | 0.00% |
| Free cash flow margin | 0.00% | (48.64%) | 0.00% |
| Return on equity | (81.57%) | (16.22%) | (57.72%) |
| Return on assets | (60.29%) | (14.89%) | (49.22%) |
| Return on invested capital | (1,956.27%) | (36.65%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack